<DOC>
	<DOC>NCT01620333</DOC>
	<brief_summary>This trial is conducted in Japan. The aim of this trial is to investigate the pharmacokinetics of biphasic insulin aspart 50 (NN-X14Mix50) and biphasic insulin aspart 70 (NN-X14Mix70) in Japanese healthy volunteers.</brief_summary>
	<brief_title>Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec, insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin, Long-Acting</mesh_term>
	<criteria>Healthy Japanese Body Mass Index (BMI) of 1927 kg/m^2 (both inclusive) Fasting blood glucose between 3.86 mmol/L (68.4108.0 mg/dL) (both inclusive Considered generally healthy upon completion of medical history and physical examination, as judged by the Investigator or SubInvestigator Clinically significant abnormal haematology or biochemistry screening tests, as judged by the Investigator or SubInvestigator(s) Any serious systemic infectious disease that occurred during the 4 weeks prior to the screening, as judged by the Investigator or SubInvestigator Any intercurrent illness that may affect blood glucose, as judged by the Investigator or SubInvestigator Hepatitis B or C, or HIV (human immunodeficiency virus) Use of prescription drugs within 2 weeks preceding the screening Use of nonprescription drugs, except routine vitamins or drugs that may not Blood donation of more than 1150 mL within the last 12 months Subjects with a first degree relative with diabetes mellitus History of or presence of diabetes History of or presence of cancer or any clinically significant cardiac, respiratory, metabolic, renal, hepatic, gastrointestinal, endocrinological, dermatological, venereal, haematologic, neurologic, or psychiatric diseases or disorder Previous history of serious allergy or anaphylactic reaction Subjects who consume more than 28 units of alcohol per week or who have a significant history of alcoholism or drug/chemical abuse Subjects who smoke more than 5 cigarettes per day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>